Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Solventum Corporation SOLV

Healthcare  —  Medical Instruments & Supplies
89.50 0.91 1.03% as of 25 Sep
Market cap
$15.1B
P/E
10.9×
S&P 500 Member Revenue Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Solventum Corporation (SOLV) EV/Sales

As of 25 September 2026, Solventum Corporation (SOLV) trades at a EV/Sales of 2.4×. Over the past ten years it has ranged from 1.4× (March 2024) to 2.6× (February 2025); the current reading is higher than 90% of that period. That is below the Medical Instruments & Supplies industry median of 3.1× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 2.2× (4.23%)
FY2024 2.3× 36.26%
FY2023 1.7× 0.00%
FY2022 1.7× —

Quarterly

Period EV/Sales Change
Jun 2026 2.2× 12.43%
Mar 2026 1.9× (10.13%)
Dec 2025 2.2× 11.65%
Sep 2025 1.9× (21.02%)
10 more quarters

Against its own ten years

Low 1.4× High 2.6×
Ten-year median 2.3×
Current reading's percentile 90

EV/Sales against peers

Company EV/Sales
BAX Baxter International Inc. compare 1.7×
AVTR Avantor, Inc. compare 2.1×
ALGN Align Technology, Inc. compare 2.3×
ATR AptarGroup, Inc. compare 2.3×
SOLV Solventum Corporation 2.4×
COO The Cooper Companies, Inc. compare 3.1×
ALC Alcon compare 3.2×
WST West Pharmaceutical Services, Inc. compare 7.8×
RGEN Repligen Corporation compare 13.4×
Medical Instruments & Supplies industry median 3.1×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on SOLV